The Food and Drug Administration approved brexanolone, an intravenous medication specifically designed to treat postpartum depression that is expected to be sold under the brand name Zulresso in June, for a hefty price tag of about $34,000. The drug works quickly, with effects taking place within 48 hours. However, the medication itself is delivered by […]
